市場調查報告書

HPV檢驗和幼犬檢驗市場:2019-2025

HPV Testing and Pap Test Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 949644
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
HPV檢驗和幼犬檢驗市場:2019-2025 HPV Testing and Pap Test Market 2019-2025
出版日期: 2020年06月23日內容資訊: 英文
簡介

在預測期內,預計全球HPV和PAP檢查市場將顯著增長。 HPV和PAP測試過程涉及診斷女性宮頸癌和癌前病變的過程。癌前狀態被理解為人乳頭瘤病毒(HPV)引起的細胞變化,如果不能立即治療這些異常,則可能導致宮頸癌。進行了HPV測試以尋找宮頸細胞中的HPV,以防止子宮頸癌的進一步發展。促進市場增長的因素包括全球範圍內宮頸癌病例的增加。例如,根據世界衛生組織的數據,2018年有570,000例新病例登記,佔所有女性癌症人口的6.6%。

從地理上講,北美有望佔有很大的市場佔有率。 HPV和Pap檢測市場的增長歸因於北美地區懷疑患有子宮頸癌的女性人數的增長。預計在預測期內,亞太地區市場將顯著增長。

本報告對全球HPV和PAP測試市場進行了調查,按測試類型,區域和進入市場的公司的概況提供了該市場的概述以及趨勢。

內容

第1章報告概述

第2章市場概述和見解

  • 調查範圍
  • 分析師見解和當前市場趨勢
  • 規則與規定

第3章競爭情況

  • 主要策略分析
  • 主要公司分析
    • Abbott Laboratories Inc.
    • F. Hoffmann-La Roche Ltd.
    • Becton, Dickinson and Co.
    • Qiagen NV
    • Quest Diagnostics Inc.

第4章市場決定因素

動機

約束/問題

  • 機會

第5章市場細分

  • 按檢驗類型劃分的市場

第6章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章公司簡介

  • Abbott Laboratories Inc.
  • Arbor Vita Corp.
  • Becton, Dickinson and Co.
  • BioMerieux SA
  • Cepheid Inc.
  • Diagcor Bioscience Inc. Ltd
  • Diagnostic Laboratory Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genera Biosystems Ltd.
  • GENOMICA SA
  • Greiner Bio-One International GmbH
  • Hologic, Inc.
  • HybriBio Ltd.
  • Laboratory Corp of America Holdings
  • Mikrogen Molekularbiologische Entwicklungs Gmbh
  • NURX Inc.
  • PreTect AS
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Seegene, Inc.
  • TAKARA SHUZO Co., Ltd.
目錄
Product Code: OMR2021963

Global HPV Testing and Pap Test Market Size, Share & Trends Analysis Report By Test Type (HPV Test, PAP Test, and Co-Testing), and Forecast 2019-2025

The global HPV testing and Pap test market are anticipated to grow significantly during the forecast period.HPV testing and Pap test process involve the process of diagnosing the cancers and precancers in the cervix of women. Precancers can be understood as cell changes that can be caused by the human papillomavirus (HPV) and if the treatment of these abnormal cannot be done on time, they can lead to cervical cancer. An HPV test is done to looks for HPV in cervical cells to prevent the future development of cervical cancer. The factor contributing to the growth of the market includes increasing cervical cancer cases across the globe. For instance, according to the World Health Organization, an estimated 570,000 new cases were registered in 2018 representing 6.6% of all female cancer population.

The HPV testing and Pap test market is segmented based on test type and application. Based on the test type, the market is sub-segmented into the HPV test, Pap test, and Co-testing. Pap test segment is anticipated to hold a significant share in the market. Further, researchers across the globe are conducting collaborative studies for discovering the advantages of combining the HPV and Pap tests for the early diagnosis reproductive tract cancer in women. This in tur, tend to drive the global HPV testing and Pap test market during the forecast period.

Geographically, the study of the global HPV testing and Pap test market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. North America is expected to contribute a significant share in the market. The growth in HPV testing and the Pap test market is owing to an increase in the number of the female population that are suspect of cervical cancer in the North American region. Asia-Pacific is estimated to exhibit a significant growth rate in the global HPV testing and Pap test market during the forecast period.

Some of thekey players of the global HPV testing and Pap test market includeAbbott Laboratories Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Co., Qiagen NV, Quest Diagnostics Inc., Quest Diagnostics Inc., Seegene, Inc., TAKARA SHUZO Co., Ltd., and others.

Research Methodology

The market study of the global HPV testing and Pap testmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the pharmaceutical industry, hospitals& clinics, diagnostic centers,medical device companies, government organizations, regulatory bodies, and other related organizations for overall market analysis and competitive analysis.The report provides an in-depth analysis of market size, products offered by the company, and future growth opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. GlobalHPV Testing and Pap TestMarket Research and Analysis by Test Type

The Report Covers:

  • Comprehensive research methodology of the global HPV testing and Pap testmarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global HPV testing and Pap testmarket.
  • Insights about market determinants which are stimulating the global HPV testing and Pap testmarket.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Key Strategy Analysis
  • 3.2. Key Company Analysis
    • 3.2.1. Abbott Laboratories Inc.
      • 3.2.1.1. Overview
      • 3.2.1.2. Financial Analysis
      • 3.2.1.3. SWOT Analysis
      • 3.2.1.4. Recent Developments
    • 3.2.2. F. Hoffmann-La Roche Ltd.
      • 3.2.2.1. Overview
      • 3.2.2.2. Financial Analysis
      • 3.2.2.3. SWOT Analysis
      • 3.2.2.4. Recent Developments
    • 3.2.3. Becton, Dickinson and Co.
      • 3.2.3.1. Overview
      • 3.2.3.2. Financial Analysis
      • 3.2.3.3. SWOT Analysis
      • 3.2.3.4. Recent Developments
    • 3.2.4. Qiagen NV
      • 3.2.4.1. Overview
      • 3.2.4.2. Financial Analysis
      • 3.2.4.3. SWOT Analysis
      • 3.2.4.4. Recent Developments
    • 3.2.5. Quest Diagnostics Inc.
      • 3.2.5.1. Overview
      • 3.2.5.2. Financial Analysis
      • 3.2.5.3. SWOT Analysis
      • 3.2.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints/Challenges
    • 4.1. Opportunities

5. Market Segmentation

  • 5.1. HPV testing and Pap test Market by Test Type
      • 5.1.1.1. HPV Test
      • 5.1.1.2. PAP Test
      • 5.1.1.3. Co-Testing

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. Arbor Vita Corp.
  • 7.3. Becton, Dickinson and Co.
  • 7.4. BioMerieux SA
  • 7.5. Cepheid Inc.
  • 7.6. Diagcor Bioscience Inc. Ltd
  • 7.7. Diagnostic Laboratory Services, Inc.
  • 7.8. F. Hoffmann-La Roche Ltd.
  • 7.9. Genera Biosystems Ltd.
  • 7.10. GENOMICA SA
  • 7.11. Greiner Bio-One International GmbH
  • 7.12. Hologic, Inc.
  • 7.13. HybriBio Ltd.
  • 7.14. Laboratory Corp of America Holdings
  • 7.15. Mikrogen Molekularbiologische Entwicklungs Gmbh
  • 7.16. NURX Inc.
  • 7.17. PreTect AS
  • 7.18. QIAGEN NV
  • 7.19. Quest Diagnostics Inc.
  • 7.20. Seegene, Inc.
  • 7.21. TAKARA SHUZO Co., Ltd.

LIST OF TABLES

  • 1. GLOBAL HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL HPV TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL PAP TESTMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL CO-TESTINGMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 6. NORTH AMERICANHPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 7. NORTH AMERICAN HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)
  • 8. EUROPEANHPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 9. EUROPEANHPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)
  • 10. ASIA-PACIFIC HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 11. ASIA-PACIFIC HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)
  • 12. REST OF THE WORLD HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HPV TESTING AND PAP TEST MARKET SHARE BY TEST TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL HPV TESTING AND PAP TEST MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 3. US HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 4. CANADA HPV TESTING AND PAP TEST MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. UK HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 6. FRANCE HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 7. GERMANY HPV TESTING AND PAP TEST MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. ITALY HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 9. SPAIN HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ROE HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 11. INDIA HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 12. CHINA HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 13. JAPAN HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 14. REST OF ASIA-PACIFIC HPV TESTING AND PAP TEST MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF THE WORLD HPV TESTING AND PAP TEST MARKET SIZE, 2018-2025 ($ MILLION)